Medical Equipment

Implantable Collamer Lens Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

March 12, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Implantable Collamer Lens Market During The Forecast Period 2026–2030?

The implantable collamer lens market has demonstrated substantial growth in recent years. This market is set to expand from $20.77 billion in 2025 to $22.2 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. The factors contributing to its historical growth include an increasing prevalence of refractive vision disorders, a rising demand for surgical vision correction, advancements in ophthalmic implant technology, the growing acceptance of ICL procedures, and the expansion of specialized ophthalmic clinics.

The implantable collamer lens market is projected to experience robust expansion over the coming years, reaching a valuation of $28.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This anticipated growth during the forecast period is primarily driven by several factors, including the wider acceptance of premium vision correction methods, a heightened emphasis on less invasive ophthalmic surgeries, the proliferation of elective eye care treatments, increasing financial commitments to cutting-edge ophthalmology technologies, and improved patient understanding of the advantages of ICLs. Key trends expected within this period encompass the greater uptake of EVO implantable collamer lenses, the increasing implementation of laser-guided implantation methods, a surging preference for reversible vision correction options, the development of more personalized lens designs, and an intensified focus on maintaining visual stability over extended periods.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20840&type=smp

Which Economic Or Industry Drivers Are Impacting The Implantable Collamer Lens Market?

The growing occurrence of vision impairments is projected to propel the implantable collamer lens market in the future. Vision disorders are defined as conditions impacting the clarity of sight, marked by a progressive reduction in visual sharpness and overall eye well-being. These disorders are escalating worldwide, influenced by factors such as an aging demographic, increased exposure to digital screens, and the rising incidence of conditions like myopia and age-related macular degeneration. Implantable Collamer Lenses (ICLs) present an efficacious remedy for correcting vision disorders, including myopia, hyperopia, and astigmatism, by serving as a secure, reversible option when compared to conventional refractive surgeries such as LASIK. For example, in August 2023, a report from the World Health Organization, a Switzerland-based specialized agency of the United Nations, indicated that over 2.2 billion individuals globally experience near or distance vision impairment, with 1 billion of these instances being either preventable or currently untreated. Consequently, the expanding prevalence of vision disorders is fueling the expansion of the implantable collamer lens market.

What Market Segments Are Evaluated Within The Implantable Collamer Lens Market?

The implantable collamer lens market covered in this report is segmented –

1) By Type: Visian Implantable Collamer Lens (ICL), EVO Implantable Collamer Lens (ICL)

2) By Technology Adoption: Laser-Assisted Techniques, Traditional Techniques

3) By Application: Myopia, Hyperopia, Astigmatism

4) By End User: Ophthalmic Clinics, Hospitals, Ambulatory Surgical Center, Other End User

Subsegments:

1) By Visian Implantable Collamer Lens (ICL): Visian ICL for Myopia, Visian ICL For Hyperopia, Visian ICL For Astigmatism, Visian ICL For Presbyopia

2) By EVO Implantable Collamer Lens (ICL): EVO ICL For Myopia, EVO ICL For Hyperopia, EVO ICL For Astigmatism, EVO ICL For Presbyopia

What Industry Trends Are Redefining The Implantable Collamer Lens Market?

Leading companies in the implantable collamer lens market are prioritizing technological advancements, such as biocompatible, minimally invasive lens implants that address a wide range of refractive errors without the removal of corneal tissue. This focus aims to enhance patient outcomes and reduce their reliance on glasses and contact lenses. Biocompatible Minimally Invasive Implantable Lenses enable safe, reversible vision correction by integrating with the natural anatomy of the eye, providing rapid procedures and high patient satisfaction. For instance, in March 2024, STAAR Surgical Company, a U.S.-based ophthalmic medical device company, announced that over three million EVO ICL lenses have been implanted globally. The EVO ICL corrects myopia, with or without astigmatism, and presbyopia, via a 20–30 minute procedure that positions the lens between the iris and the natural crystalline lens. This biocompatible, removable lens offers a next-generation alternative to glasses and contacts, assisting millions of patients in achieving improved vision safely and effectively.

Who Are The Top Market Participants Influencing The Implantable Collamer Lens Market?

Major companies operating in the implantable collamer lens market are STAAR Surgical Company, Care Group Sight Solutions (IPCL), Ophtec (Artisan Phakic IOLs), Rayner Surgical, Hoya Surgical Optics, Alcon Inc., Johnson & Johnson Vision/Abbott Medical Optics, Bausch + Lomb, Carl Zeiss Meditec AG, Nidek Co. Ltd., Lenstec Inc., SIFI S.p.A., Optimedical, Eyeonics (now part of Santen)*, Physiol LLC, Microlens Tech Co. Ltd., HumanOptics AG, Ocular Instruments Inc., Aaren Scientific LLC, Visiogen Inc.

Read the full implantable collamer lens market report here:

https://www.thebusinessresearchcompany.com/report/implantable-collamer-lens-global-market-report

What Are The Top-Performing Regions Within The Implantable Collamer Lens Market?

North America was the largest region in the implantable collamer lens market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable collamer lens market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Implantable Collamer Lens Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20840&type=smp

Browse Through More Reports Similar to the Global Implantable Collamer Lens Market 2026, By The Business Research Company

Corneal Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/corneal-implants-global-market-report

Prescription Lens Market Report 2026

https://www.thebusinessresearchcompany.com/report/prescription-lens-global-market-report

Cataract Surgery Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cataract-surgery-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795